Found: 44
Select item for more details and to access through your institution.
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 19, p. 17597, doi. 10.1007/s00432-023-05461-z
- By:
- Publication type:
- Article
Effects of immunosuppressive treatment on patient outcomes after immune checkpoint inhibitor-related gastrointestinal toxicity.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7793, doi. 10.1007/s00432-023-04736-9
- By:
- Publication type:
- Article
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3065, doi. 10.1007/s00432-022-04206-8
- By:
- Publication type:
- Article
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 2, p. 475, doi. 10.1007/s00432-021-03627-1
- By:
- Publication type:
- Article
Correlation Between Baseline Osteoprotegerin Serum Levels and Prognosis of Advanced-Stage Colorectal Cancer Patients.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 45, n. 2, p. 605, doi. 10.1159/000487101
- By:
- Publication type:
- Article
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib.
- Published in:
- 2022
- By:
- Publication type:
- journal article
IL-18 But Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8602, doi. 10.3390/ijms21228602
- By:
- Publication type:
- Article
Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 11, p. 1462, doi. 10.1111/apt.17985
- By:
- Publication type:
- Article
Inhibition of Ataxia Telangiectasia- and Rad3 -Related Function Abrogates the In Vitro and In Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133<sup>+</sup> Tumor-Initiating Cell Fraction.
- Published in:
- Stem Cells, 2011, v. 29, n. 3, p. 418, doi. 10.1002/stem.595
- By:
- Publication type:
- Article
Genetic inactivation of the Fanconi anemia geneFANCC identified in the hepatocellular carcinomacell line HuH-7 confers sensitivity towardsDNA-interstrand crosslinking agents.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 127, doi. 10.1186/1476-4598-9-127
- By:
- Publication type:
- Article
Development and External Validation of the Munich Sorafenib Evaluation Score for Hepatocellular Carcinoma.
- Published in:
- Digestive Diseases, 2023, v. 41, n. 2, p. 268, doi. 10.1159/000524336
- By:
- Publication type:
- Article
Current State of Multidisciplinary Treatment in Cholangiocarcinoma.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 5, p. 581, doi. 10.1159/000520346
- By:
- Publication type:
- Article
Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art Review.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 5, p. 565, doi. 10.1159/000520095
- By:
- Publication type:
- Article
A Simple Prognostic Scoring System for Hepatocellular Carcinoma Treated with Selective Internal Radiation Therapy.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 3, p. 322, doi. 10.1159/000517458
- By:
- Publication type:
- Article
Biliary Cannulation in Endoscopic Retrograde Cholangiography: How to Tackle the Difficult Papilla.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 1, p. 85, doi. 10.1159/000515692
- By:
- Publication type:
- Article
Prevalence, Resistance Rates, and Risk Factors of Pathogens in Routine Bile Cultures Obtained during Endoscopic Retrograde Cholangiography.
- Published in:
- Digestive Diseases, 2021, v. 39, n. 1, p. 42, doi. 10.1159/000509289
- By:
- Publication type:
- Article
Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056760
- By:
- Publication type:
- Article
Microsatellite Instability, KRAS Mutations and Cellular Distribution of TRAIL-Receptors in Early Stage Colorectal Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051654
- By:
- Publication type:
- Article
Cell Cycle Progression or Translation Control Is Not Essential for Vesicular Stomatitis Virus Oncolysis of Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2010, v. 5, n. 6, p. 1, doi. 10.1371/journal.pone.0010988
- By:
- Publication type:
- Article
Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) – a multicenter, randomized, controlled, open-label investigator-initiated trial.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12693-w
- By:
- Publication type:
- Article
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5966, doi. 10.3390/cancers14235966
- By:
- Publication type:
- Article
TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5240, doi. 10.3390/cancers14215240
- By:
- Publication type:
- Article
Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3830, doi. 10.3390/cancers12123830
- By:
- Publication type:
- Article
Antifibrotic Properties of Transarterial Oncolytic VSV Therapy for Hepatocellular Carcinoma in Rats With Thioacetamide-Induced Liver Fibrosis.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 11, p. 2032, doi. 10.1038/mt.2013.181
- By:
- Publication type:
- Article
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 6, doi. 10.1159/000530700
- By:
- Publication type:
- Article
HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.717792
- By:
- Publication type:
- Article
Overexpression of heat shock protein 27 ( HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.
- Published in:
- Journal of Cellular & Molecular Medicine, 2015, v. 19, n. 2, p. 340, doi. 10.1111/jcmm.12444
- By:
- Publication type:
- Article
Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 8, p. 1776, doi. 10.1111/j.1582-4934.2011.01473.x
- By:
- Publication type:
- Article
Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells.
- Published in:
- Journal of Translational Medicine, 2023, p. 1, doi. 10.1186/s12967-023-04615-4
- By:
- Publication type:
- Article
Stereotaktische Bestrahlungstherapie bei Patienten mit hepatozellulärem Karzinom im Rahmen multimodaler Behandlung.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Checkpoint Inhibitors: The Diagnosis and Treatment of Side Effects.
- Published in:
- Deutsches Ärzteblatt International, 2019, v. 116, n. 8, p. 119, doi. 10.3238/arztebl.2019.0119
- By:
- Publication type:
- Article
Prediction of <sup>90</sup>Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 769, doi. 10.2967/jnumed.117.200758
- By:
- Publication type:
- Article
The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma.
- Published in:
- Cell Death Discovery, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41420-019-0165-7
- By:
- Publication type:
- Article
The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma.
- Published in:
- Digestion, 2019, v. 100, n. 1, p. 15, doi. 10.1159/000493136
- By:
- Publication type:
- Article
Contrast-Enhanced Ultrasound in the Follow-Up of Choroidal Melanoma Patients: Features of Liver Metastasis Arising Several Years after Treatment of the Primary Tumor.
- Published in:
- Case Reports in Oncology, 2011, v. 4, n. 2, p. 336, doi. 10.1159/000329453
- By:
- Publication type:
- Article
Clinical Evidence on the Interaction Between MLK4, KRAS and Microsatellite Instability to Determine the Prognosis of Early-Stage Colorectal Carcinoma.
- Published in:
- Cellular Physiology & Biochemistry (Cell Physiol Biochem Press GmbH & Co. KG), 2019, v. 53, n. 5, p. 820, doi. 10.33594/000000175
- By:
- Publication type:
- Article
The Novel mTOR Inhibitor RAD001 (Everolimus) Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells.
- Published in:
- Neuroendocrinology, 2007, v. 85, n. 1, p. 54, doi. 10.1159/000100057
- By:
- Publication type:
- Article
The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4<sup>-/-</sup> Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology.
- Published in:
- Aging & Disease, 2024, v. 15, n. 1, p. 338, doi. 10.14336/AD.2023.0602
- By:
- Publication type:
- Article
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non–Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2.
- Published in:
- Oncologist, 2022, v. 27, n. 12, p. e938, doi. 10.1093/oncolo/oyac183
- By:
- Publication type:
- Article
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
- Published in:
- Cellular Oncology (2211-3428), 2019, v. 42, n. 5, p. 705, doi. 10.1007/s13402-019-00458-8
- By:
- Publication type:
- Article
Performance evaluation of the Elecsys PIVKA‐II and Elecsys AFP assays for hepatocellular carcinoma diagnosis.
- Published in:
- JGH Open, 2022, v. 6, n. 5, p. 292, doi. 10.1002/jgh3.12720
- By:
- Publication type:
- Article
Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated Colitis.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 14, p. 2686, doi. 10.7150/jca.86635
- By:
- Publication type:
- Article
EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells.
- Published in:
- Biological Chemistry, 2009, v. 390, n. 12, p. 1293, doi. 10.1515/BC.2009.140
- By:
- Publication type:
- Article